Citius Oncology, Inc. CTOR Balance Sheet Statement
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| $2.63M+2,350,466% | $7.3M+6,513,696% | $3.92M+3,504,282% | $112-57.1% | $112-99.7% | ||
| —— | —— | —— | —— | —— | ||
| $84.79M+120% | $77.47M+227% | $69.22M+601% | $55.2M— | $38.52M— | ||
| $29.42M+63.1% | $37.15M+117% | $27.54M+151% | $18.31M+44,569% | $18.04M+19,011% | ||
| $100.7M+10.1% | $109.97M+21.5% | $100.94M+19.6% | $91.71M+86.4% | $91.44M+87.8% | ||
| $8.88M— | $10.45M— | $13.23M— | $8.67M— | —— | ||
| $58.81M+18.2% | $44.71M+3.0% | $49.49M+51.3% | $52.99M+1,620% | $49.74M+1,664% | ||
| $65.43M— | $51.56M— | $56.08M— | $59.31M— | —— | ||
| 400M+300% | 400M+300% | 400M+264% | 400M+167% | 100M-33.3% | ||
| -$96.18M-79.2% | -$69.57M-51.5% | -$64.04M-63.0% | -$59.04M-1,842% | -$53.67M-2,085% | ||
| $35.27M-1.0% | $58.41M+41.5% | $44.87M-2.8% | $32.4M+90.2% | $35.64M+79.6% | ||
| $100.7M+10.1% | $109.97M+21.5% | $100.94M+19.6% | $91.71M+86.4% | $91.44M+87.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Citius Oncology, Inc.'s total assets?
- Citius Oncology, Inc. (CTOR) holds $100.7M in total assets, up 10.1% year over year.
- How much cash does Citius Oncology, Inc. have?
- Citius Oncology, Inc. holds $2.6M in cash and equivalents.
- Can Citius Oncology, Inc. cover its short-term obligations?
- Its current ratio is 0.50 — current liabilities exceed current assets.
- Where does Citius Oncology, Inc.'s balance sheet data come from?
- Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.